Efficacy and survival of nivolumab treatment for recurrent/unresectable esophageal squamous-cell carcinoma: real-world clinical data from a large multi-institutional cohort.
Tomoki MakinoShigeto NakaiKota MomoseKotaro YamashitaKoji TanakaHiroshi MiyataSachiko YamamotoMasaaki MotooriYutaka KimuraYuki UshimaruMotohiro HiraoJin MatsuyamaYusuke AkamaruYukinori KurokawaHidetoshi EguchiYuichiro DokiPublished in: Esophagus : official journal of the Japan Esophageal Society (2024)
UMIN000040462.